Haleon plc
- Jurisdiction
United Kingdom - LEI
549300PSB3WWEODCUP19 - ISIN
US4055521003 (HLN )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€3.70 109.4% overvalued - Financial strength (Piotroski F-Value)
-
7
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Read full profile
Fundamentals
- Net revenue
€12.64B - Gross margin
61.8% - EBIT
€2.59B - EBIT margin
20.5% - Net income
€1.75B - Net margin
13.8%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
- Last dividend amount
-
$0.06 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
27.3%
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Val Hoyle | September 12, 2025 | $1.00K–$15.00K |
| Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
| Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
| Josh Gottheimer | May 14, 2025 | $1.00K–$15.00K |
| Josh Gottheimer | July 9, 2024 | $1.00K–$15.00K |
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Buy |
| John D. Spears |
|
|
|
Sell |
Earnings Calls
Latest earnings call: July 31, 2025 (Q2 2025)